|
|
Article: Bone Solutions Inc. (BSI) receives FDA 510(K) clearance for worlds first and only magnesium-based bone void filler, OsteoCrete.
- Article from:
- Blood Weekly
- Article date:
- June 25, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Bone Solutions Inc. (BSI) announced that it has received FDA 510(k) clearance for the first device in its technology pipeline--a proprietary bone void filler, OsteoCrete™, which represents a critical milestone in the Company's efforts to establish a platform for its patented magnesium-based technology.
The Company expects this milestone to trigger its long-term plan to establish its platform as the 'one-stop bone-, tendon- and ligament-injectable, biodegradable adhesive technology' for surgeries at hospitals, clinics and other private surgical centers within the orthopedic industry (see also Tissue Engineering).
"BSI's OsteoCrete™, now ...